跳至主要内容
临床试验/NCT02362802
NCT02362802已完成不适用

Myocardial Minimal Damage After Rapid Ventricular Pacing

Deutsches Herzzentrum Muenchen2 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
149
试验地点
2
主要终点
High sensitive Troponin

研究概览

简要总结

This study aims to investigate the impact of antitachycardia pacing ( ATP) on the myocardial tissue with respect to its potential micro damage measured by several myocardial markers, especially by high-sensitive TroponinT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients for de-novo implantation of a transvenous ICD (single chamber, dual chamber or cardiac resynchronization tehrapy) with left pectoral device position and planned apical location of the right ventricular defibrillation electrode.

排除标准

  • Resuscitation, cardiac surgical procedure, acute coronary syndrome, acute myocardial infarction, coronary revascularisation, cardioversion or ablation during the past 4 weeks, if baseline high-sensitive Troponin T is elevated
  • Known stenosis of coronary vessels with indication for coronary intervention or operative revascularisation
  • Intracardiac thrombus or general contraindication against ventricular burst stimulation or intraoperative ICD-testing
  • Atypical lead implantation with indication for defibrillation threshold testing by induction of ventricular fibrillation
  • Right sided implantation of ICD
  • Planned electrical cardioversion
  • Lead explantation or -extraction during procedure
  • Redo procedure (except of additional implantation of a right ventricular ICD lead)
  • Present temporary pacemaker electrode
  • ASA >= IV or NYHA IV
  • Cardiogenic shock
  • Pulmonary embolism, cerebrovascular insult or dialysis in the past 4 weeks
  • Lack of consent of patient
  • Minority of patient

结局指标

主要结局

High sensitive Troponin

时间窗: 14-20 hours

次要结局

未报告次要终点

研究者

发起方
Deutsches Herzzentrum Muenchen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Adnan Kastrati, MD

PD Dr. med. C. Kolb

Deutsches Herzzentrum Muenchen

研究点 (2)

Loading locations...

相似试验